Pancreatic islet cell transplantation is considered one of the most advanced medical developments, offering new hope for patients with diabetes, especially those who struggle to control blood sugar levels despite using insulin and conventional treatments. This procedure involves transferring specialized cells responsible for insulin production into the patient’s body, aiming to restore the body’s ability to regulate blood sugar naturally or nearly naturally. This can reduce the risk of complications and significantly improve quality of life.
With significant advancements in transplantation techniques and immunotherapy, pancreatic islet cell transplantation has become a promising therapeutic option in selected cases. It can help reduce the need for insulin injections, prevent severe hypoglycemic episodes, and achieve better glucose stability.In this Dalily Medical article, we will explore in detail pancreatic islet cell transplantation, including its indications, types, procedural steps, success rates, potential complications, and essential tips to ensure long-term success of the procedure.
Pancreatic islet cell transplantation is a modern medical procedure in which insulin-producing pancreatic cells are transferred from a donor to a patient with diabetes. These cells are typically transplanted into the liver, where they can better regulate blood sugar levels and improve diabetes control.
Can diabetes be completely cured after the procedure?
Some patients may be able to stop using insulin for a limited period.
Others may require lower doses than usual.
However, the procedure is not considered a permanent cure for all cases. Its primary goal is to improve blood sugar control and reduce complications.
Is the procedure painful?
The procedure is usually minimally painful.
Local anesthesia or sedatives are used to minimize discomfort during the procedure.
Patients may experience mild pain afterward, which typically resolves within a few days.
Is the procedure safe?
The procedure is generally considered safe, especially when performed in specialized medical centers.
Serious complications are rare, and most patients recover quickly, returning to their normal daily activities after a short period.
How long do the transplanted cells remain effective?
Transplanted cells may remain functional for several years.
The duration varies depending on the patient’s health and the number of transplanted cells.
Some patients may require additional transplants in the future to maintain optimal blood sugar control.
Can the procedure be repeated?
Yes, in some cases, islet cell transplantation can be repeated to improve outcomes or compensate for declining function of the transplanted cells over time.
Where are islet cells transplanted in the body?
The most common site is the liver via the portal vein, where the cells settle and begin producing insulin naturally.
Pancreatic islet cell transplantation offers significant health benefits for diabetic patients, particularly those with type 1 diabetes or insulin-dependent conditions:
Improved Blood Sugar Control
The transplant helps stabilize blood glucose levels, reducing sudden spikes or drops.
This makes blood sugar readings more predictable and easier to manage.
Reduced Dependence on Insulin
Many patients can reduce or temporarily stop insulin use after the procedure.
This eases the burden of daily injections and improves quality of life.
Enhanced Quality of Life
Better blood sugar control and reduced insulin reliance increase energy, improve mood, and allow patients to engage in daily activities with less worry.
Long-Term Health Benefits
Successful transplantation reduces the risk of chronic diabetes complications, such as:
Kidney disease
Neuropathy
Cardiovascular diseases
This contributes to longer and healthier life expectancy.
Psychological Benefits
The procedure alleviates the psychological burden of diabetes, reducing stress and anxiety associated with daily disease management.
Proper preparation increases the procedure’s success rate and reduces risks. Key preparation steps include:
Comprehensive Evaluation
Medical history review and physical examination
Blood tests and imaging
Assessment of heart and lung function
Consultation with a Multidisciplinary Team
Team includes endocrinologists, transplant surgeons, nutritionists, and mental health specialists.
Discussions cover:
Procedural steps
Potential risks
Post-transplant care
Lifestyle Modifications
Patients may be advised to make simple changes to improve health and increase success, such as:
Healthy diet
Regular physical activity
Smoking cessation
Understanding Immunosuppressive Therapy
These medications are crucial to prevent rejection of transplanted cells.
Patients must:
Take medications regularly
Understand potential side effects
Following Pre-Procedure Instructions
Includes permitted and restricted medications
Dietary limitations
Any adjustments to diabetes management plan before transplantation
Support System
Family and friends’ support is essential for emotional and practical assistance before and after the procedure.
Financial Considerations
Discuss costs and insurance coverage with the healthcare team to avoid surprises.
Psychological and Emotional Preparation
Mental preparation is as important as physical readiness.
Options include:
Counseling sessions
Support groups to manage anxiety and fear before the procedure
Pancreatic islet cell transplantation is a specialized treatment designed to restore the body’s ability to regulate blood sugar naturally or nearly naturally, particularly when conventional methods fail.
Severe Type 1 Diabetes
Patients with long-standing type 1 diabetes who have difficulty controlling blood sugar despite optimal medical care are prime candidates.
This includes patients with frequent, hard-to-detect, or uncontrolled hypoglycemic episodes.
Diabetes-Related Complications
Candidates may include patients with complications such as:
Diabetic nephropathy (kidney disease)
Diabetic retinopathy (eye problems)
Neuropathy (nerve damage)
The procedure can help reduce complications and improve overall health.
Reducing Insulin Dependence
Patients seeking to reduce or partially eliminate insulin use can benefit.
This is especially relevant for those burdened by daily diabetes management.
Age and General Health
Typically, candidates are between 18 and 65 years old.
Patients should be generally healthy without major conditions that complicate surgery or recovery.
Psychological and Social Factors
Assessment of mental and emotional health is crucial.
Patients must be able to adhere to post-transplant care, including lifelong immunosuppressive therapy.
Positive Donor Match
Successful donor-recipient matching is critical.
Good compatibility reduces the risk of immune rejection of transplanted cells.
Biological and Medical Criteria
Preferred candidates have low or undetectable C-peptide levels, indicating reduced endogenous insulin production.
Persistent high HbA1c (>7.5%-8%) despite intensive insulin therapy, especially with hypoglycemia unawareness, strengthens the indication for transplantation.
Pancreatic islet cell transplantation is not a single procedure but has several types depending on the source of the cells, the patient’s condition, and the transplantation goal:
Allogeneic Islet Transplant
Concept: Islet cells are taken from a deceased donor and transplanted into the patient’s liver via the portal vein.
Used for:
Type 1 diabetes
Unstable blood sugar levels
Severe hypoglycemic episodes
Advantage: May reduce or eliminate the need for insulin.
Disadvantage: Patients require lifelong immunosuppressive medication.
Autologous Islet Transplant
Concept: Islet cells are harvested from the patient’s own pancreas before its removal and transplanted back into the liver.
Used for:
Total pancreatectomy
Severe chronic pancreatitis
Advantage: No immunosuppressive drugs are needed because the cells come from the patient’s own body.
Islet Transplant Alone (ITA)
Concept: Islet cells are transplanted without any other organ.
Used for: Type 1 diabetic patients without kidney failure.
Goal: Improve blood sugar control and reduce hypoglycemic episodes.
Islet After Kidney Transplant (IAK)
Concept: Kidney is transplanted first, followed by islet cell transplantation.
Used for: Type 1 diabetic patients with kidney failure.
Advantage: Patients are already on immunosuppressive drugs, which facilitates acceptance of the islet cells.
Simultaneous Islet-Kidney Transplant (SIK)
Concept: Islet cells and kidney are transplanted at the same time.
Used for: Type 1 diabetic patients with severe kidney failure.
Goal: Treat both diabetes and kidney failure simultaneously.
Encapsulated Islet Transplant – Experimental
Concept: Islet cells are placed inside tiny capsules that allow insulin to pass through but protect the cells from the immune system.
Advantage: Patients may not require immunosuppressive drugs.
Status: Still under development in most countries.
Stem Cell-Derived Islet Transplant
Concept: New islet cells are created from stem cells and transplanted into the patient.
Advantage: Solves the problem of donor shortage.
Status: Currently in research and experimental stages.
The method of transplantation depends on the type of islet transplant, the cell source, and the patient’s condition. The main principle in all methods is to transfer insulin-producing cells into the liver, where they begin producing insulin naturally or near-normally.
Allogeneic Islet Transplant
Steps:
Obtaining the pancreas:
Taken from a recently deceased donor.
Preserved in a special solution to maintain cell viability.
Islet cell extraction:
Pancreas is digested using specific enzymes.
Islet cells are separated from other pancreatic tissue, purified, and prepared for transplantation.
Patient preparation:
Immunosuppressive drugs are given before the procedure.
Tests are conducted to ensure liver readiness.
Cell infusion into the liver:
A catheter is inserted through the skin into the portal vein.
Islet cells are slowly infused into the liver to begin producing insulin.
Duration: 1–2 hours, without open surgery.
Autologous Islet Transplant
Steps:
Pancreatectomy: Entire pancreas is removed, usually due to chronic pancreatitis.
Islet cell extraction: The pancreas is immediately transferred to the lab for isolation and purification.
Cell transplantation: Cells are infused into the patient’s liver via the portal vein catheter.
Advantage: No immunosuppressive drugs are required because cells come from the patient’s own body.
Islet Transplant Alone (ITA)
Steps:
Islet cells are prepared from a donor.
Patient receives immunosuppressive therapy.
Cells are infused into the liver via a catheter.
Used for: Patients who do not need a kidney transplant, aiming only to improve blood sugar control.
Islet After Kidney Transplant (IAK)
Steps:
Patient has already received a kidney transplant.
Donor islet cells are prepared.
Cells are infused into the liver via catheter.
Advantage: Immunosuppressive therapy is already in place, facilitating cell acceptance.
Simultaneous Islet-Kidney Transplant (SIK)
Steps:
Kidney is transplanted surgically.
Islet cells are infused using a catheter during the same treatment period.
Goal: Treat diabetes and kidney failure simultaneously.
Encapsulated Islet Transplant
Method:
Islet cells are placed in tiny capsules and implanted under the skin or in the abdomen.
Capsules allow insulin to pass through while protecting cells from the immune system.
Advantage: Often does not require immunosuppressive drugs.
Status: New technique still under development.
Stem Cell-Derived Islet Transplant
Steps:
Islet cells are generated from stem cells in the laboratory.
Cells are prepared and infused into the liver or under the skin.
The cells gradually begin producing insulin.
Status: Still in experimental research stages.
Pancreatic islet cell transplantation is not suitable for all diabetic patients, as it involves transferring new cells into the body and requires immunosuppressive medications. Certain medical conditions may prevent the procedure to avoid complications or transplant failure:
Severe liver dysfunction
The liver is the site of islet cell transplantation, so it must be healthy.
Contraindications:
Advanced liver cirrhosis
Liver failure
Severely elevated liver enzymes
Uncontrolled chronic liver disease
Reason: Transplanted cells need a healthy liver to survive and function properly.
Active or chronic infections
Infections are a major contraindication.
Examples:
Active viral hepatitis
Severe bacterial infections
Active tuberculosis
Uncontrolled viral infections
Reason: Immunosuppressive drugs can worsen infections and endanger the patient’s life.
Severe immune disorders or autoimmune diseases
These conditions can cause strong rejection of transplanted cells.
Examples:
Uncontrolled autoimmune diseases
Severe immunodeficiency
Inability to use immunosuppressive drugs
Immunosuppressive therapy is essential to prevent rejection.
Contraindications:
Severe drug allergies
Conditions preventing safe use of these medications
Inability to adhere to therapy
Severe heart disease
Examples:
Advanced heart failure
Unstable coronary artery disease
Serious arrhythmias
Reason: The procedure may increase the risk of cardiac complications.
Severe kidney disease (in some cases)
Especially if there’s no kidney transplant plan, as immunosuppressive drugs may affect kidney function.
Active cancer
Presence of active malignancy prevents transplantation.
Note: Transplantation may be considered if cancer is fully treated and a sufficient disease-free period has passed.
Severe bleeding disorders
Examples:
Coagulation defects
Serious hematologic disorders
Reason: The procedure involves catheter insertion into blood vessels, which may cause severe bleeding.
Severe obesity
Morbid obesity may reduce the success of the procedure and increase complication risk.
Psychological issues or non-compliance
Success requires consistent follow-up, medication adherence, and regular testing.
Reason: Non-compliance may lead to transplant failure.
Although relatively safe compared to whole pancreas transplantation, islet cell transplantation carries some risks, both during and after the procedure, in the short and long term.
Internal bleeding:
Caused by catheter insertion into the portal vein.
Usually mild, rarely severe.
Symptoms: Abdominal pain, low blood pressure, decreased hemoglobin.
Portal vein thrombosis:
Rare but serious.
Blood clot forms in the vein where cells were infused, potentially obstructing blood flow to the liver.
Liver injury:
Minor liver tissue damage may occur during catheter insertion.
Usually temporary and resolves over time.
Infections: At catheter site or internally, due to immunosuppressive drugs.
Elevated liver enzymes: Liver response to transplanted cells, usually temporary.
Abdominal pain: Mild to moderate, subsides within a few days.
Early graft failure: Transplanted cells may fail due to immune rejection, cell damage during transfer, or insufficient cell number.
Immune rejection of transplanted cells: Can reduce transplant effectiveness, leading to resumed insulin use.
Side effects of immunosuppressive drugs:
Weakened immunity, higher infection risk
Kidney problems
High blood pressure and cholesterol
Increased risk of certain cancers over time
Incomplete insulin independence: Some patients reduce insulin needs but cannot stop completely.
Loss of transplanted cell function over time: Due to immune attack or cell stress.
Recovery is generally faster and easier than whole pancreas transplantation because the procedure is catheter-based rather than open surgery. However, careful monitoring is essential to ensure transplant success.
Patient is under hospital observation.
Monitoring: Blood pressure, blood sugar, liver function, possible bleeding.
Instructions:
Bed rest for 6–12 hours
Avoid vigorous movements
Observe catheter insertion site
Most patients are discharged within 1–3 days.
Symptoms: Mild abdominal pain, slight fatigue, bruising at catheter site.
Advice:
Rest at home
Avoid heavy lifting
Adhere to prescribed medications
Transplanted cells gradually begin functioning.
Expectations:
Blood sugar improves progressively
Insulin requirement may decrease or stop in some cases
Follow-up:
Daily blood sugar monitoring
Regular blood tests
Liver function monitoring
Expected results:
Stable blood sugar levels
Reduced hypoglycemic episodes
Improved quality of life
Notes:
Some patients may remain insulin-free for extended periods
Others may need small doses only
Immunosuppressive drugs are essential to prevent rejection.
Tips:
Take them regularly at the same time each day
Do not stop without doctor’s advice
Follow doses and scheduled lab tests
Proper aftercare is crucial to ensure the success and longevity of the transplanted cells:
Adhere to immunosuppressive therapy
Prevents immune attack on transplanted cells
Take medications consistently and attend all follow-ups
Monitor blood sugar regularly
Multiple daily checks or continuous glucose monitoring
Record readings to share with your doctor
Care for catheter insertion site
Keep area clean and dry for the first two weeks
Avoid pressure or trauma
Contact the doctor if redness, swelling, severe pain, or discharge occurs
Follow a healthy diet
Reduce sugar intake
Eat vegetables, fruits, and healthy proteins
Avoid harmful fats
Stay well hydrated
Prevent infections
Wash hands frequently
Avoid contact with sick individuals and crowded places
Maintain personal hygiene, especially with weakened immunity
Gradually resume physical activity
Start with light walking after a few days
Increase activity gradually
Avoid heavy lifting or intense exercise for 2–4 weeks
Regular follow-ups with your doctor
Monitor transplant success, blood sugar, liver and kidney function, and drug levels
Maintain a healthy lifestyle
Adequate sleep
Reduce stress
Maintain a healthy weight
Avoid smoking
What's your complaint?